Cough syrup contaminated with DEG has caused ARI and the death of many children in The Gambia.

Published Date: 06 Mar 2023

USA: The syrup drug Diethylene glycol (DEG), a drug commonly used to prevent infections, is the cause of kidney disease...

Read Full News

Latest News

Hidden Bacteria Found in Common Kidney Stones

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Cardiometabolic Control Elusive in Adults With Hypertension

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

Low eGFR Not Associated With DKA Risk in T1D

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Quadpill Strategy Gains Ground in Hypertension

Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with resistant hypertension.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Todays Updates

Biomarker Flags 10-Fold Recurrence Risk in Testicular Cancer

MiR-371 isn’t ready for the clinic yet, but it is ready for interventional trials to see if it can refine adjuvant chemotherapy decisions in stage I testicular cancer.

FDA Approves New Drug Combo for RR Multiple Myeloma

Teclistamab plus daratumumab and hyaluronidase-fihj is approved for relapsed or refractory MM after one prior line of therapy, including a proteasome inhibitor and immunomodulatory agent.

Latest News

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with resistant hypertension.

News All Time

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

Chronic Kidney Disease Paired With Social Frailty May Increase Depression Risk

Chronic Kidney Disease Paired With Social Frailty May Increase Depression Risk

Recommended News For You

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

Oleanolic acid from grapes may increase chemotherapy effectiveness

Nanoparticle vaccine prevents multiple cancers and stops metastasis in mice

Gene therapies for BCG-unresponsive bladder cancer have high response rates.

The Effect of Common Steroids on Cancer Treatments.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

Liver cancer survival rates reflect income disparities

Recommended Articles For You

Neoadjuvant Radiotherapy & Endocrine Therapy in ER+ Breast Cancer Treatment 

The Significance of APTT Blood Test Results for Detecting Coagulation Disorders 

The Future of Hemophilia Treatment: Long-Acting Therapies and Gene Editing 

Cancer Immunotherapy: Advances, Guidelines, and Practical Tools for Modern Oncology Practice 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Fake Cancer Drugs; Let's Talk About Sex; Reducing Cancer-Related Fatigue

2.

Year in Review: Non-Small Cell Lung Cancer

3.

FDA Approves Hemophilia B Second Gene Therapy.

4.

Scientists are investigating the prevention of recurrent breast cancer, which frequently results in death.

5.

Adjunctive Cannabis Extract Improves Nausea-Vomiting Prevention in Cancer Patients

1.

Revolutionizing Cancer Treatment with Trilaciclib: How a New Drug is Transforming Outcomes

2.

Understanding QSOFA: A Vital Tool for Recognizing Sepsis 

3.

Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control

4.

Deciphering FFR: A Comprehensive Guide to Understanding Its Meaning 

5.

Optimizing the Diagnosis and Treatment of Hematological Diseases Through Artificial Intelligence

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

2.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VIII

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Efficient Management of First line ALK-rearranged NSCLC - Part VII

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot